Market Closed -
OTC Markets
01:24:34 2024-04-17 pm EDT
|
5-day change
|
1st Jan Change
|
0.0108
USD
|
+14.67%
|
|
0.00%
|
-71.58%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
127.2
|
15.34
|
25.81
|
26.95
|
19.43
|
9.846
|
Enterprise Value (EV)
1 |
206.5
|
106.2
|
128
|
127
|
121.1
|
107.1
|
P/E ratio
|
-5.84
x
|
-0.33
x
|
-1.79
x
|
-1.8
x
|
-2.36
x
|
-0.68
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.74
x
|
0.21
x
|
0.39
x
|
0.37
x
|
0.37
x
|
0.72
x
|
EV / Revenue
|
2.82
x
|
1.45
x
|
1.93
x
|
1.76
x
|
2.3
x
|
7.86
x
|
EV / EBITDA
|
-18.1
x
|
-8.4
x
|
-30
x
|
32.7
x
|
-111
x
|
-124
x
|
EV / FCF
|
-37.8
x
|
-19.2
x
|
304
x
|
22.2
x
|
1,392
x
|
10.4
x
|
FCF Yield
|
-2.64%
|
-5.21%
|
0.33%
|
4.51%
|
0.07%
|
9.65%
|
Price to Book
|
-2.91
x
|
-0.17
x
|
-0.25
x
|
-0.23
x
|
-0.16
x
|
-0.07
x
|
Nbr of stocks (in thousands)
|
254,442
|
255,644
|
258,058
|
259,093
|
259,093
|
259,093
|
Reference price
2 |
0.4999
|
0.0600
|
0.1000
|
0.1040
|
0.0750
|
0.0380
|
Announcement Date
|
4/16/19
|
5/29/20
|
4/16/21
|
3/29/22
|
3/31/23
|
3/19/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
73.29
|
73.46
|
66.35
|
72.09
|
52.58
|
13.62
|
EBITDA
1 |
-11.42
|
-12.65
|
-4.271
|
3.883
|
-1.09
|
-0.866
|
EBIT
1 |
-13.99
|
-14.36
|
-5.408
|
3.426
|
-1.258
|
-0.901
|
Operating Margin
|
-19.09%
|
-19.55%
|
-8.15%
|
4.75%
|
-2.39%
|
-6.62%
|
Earnings before Tax (EBT)
1 |
-20.38
|
-44.42
|
-14.35
|
-14.93
|
-8.197
|
-9.619
|
Net income
1 |
-20.41
|
-44.5
|
-14.39
|
-14.94
|
-8.222
|
-13.71
|
Net margin
|
-27.85%
|
-60.58%
|
-21.69%
|
-20.72%
|
-15.64%
|
-100.71%
|
EPS
2 |
-0.0856
|
-0.1815
|
-0.0559
|
-0.0577
|
-0.0317
|
-0.0556
|
Free Cash Flow
1 |
-5.461
|
-5.53
|
0.4218
|
5.72
|
0.087
|
10.33
|
FCF margin
|
-7.45%
|
-7.53%
|
0.64%
|
7.94%
|
0.17%
|
75.85%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
147.32%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/16/19
|
5/29/20
|
4/16/21
|
3/29/22
|
3/31/23
|
3/19/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
79.3
|
90.9
|
102
|
100
|
102
|
97.2
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-6.948
x
|
-7.184
x
|
-23.94
x
|
25.76
x
|
-93.31
x
|
-112.3
x
|
Free Cash Flow
1 |
-5.46
|
-5.53
|
0.42
|
5.72
|
0.09
|
10.3
|
ROE (net income / shareholders' equity)
|
57.4%
|
67.6%
|
15.2%
|
13.6%
|
6.78%
|
7.31%
|
ROA (Net income/ Total Assets)
|
-12.1%
|
-17.7%
|
-10.3%
|
7.16%
|
-3.43%
|
-3.77%
|
Assets
1 |
168.4
|
252
|
139.1
|
-208.7
|
239.4
|
364.2
|
Book Value Per Share
2 |
-0.1700
|
-0.3400
|
-0.4000
|
-0.4500
|
-0.4800
|
-0.5400
|
Cash Flow per Share
2 |
0.0200
|
0
|
0
|
0.0100
|
0
|
0
|
Capex
1 |
0.06
|
0.02
|
0.02
|
0.16
|
0.1
|
-
|
Capex / Sales
|
0.08%
|
0.03%
|
0.03%
|
0.22%
|
0.19%
|
-
|
Announcement Date
|
4/16/19
|
5/29/20
|
4/16/21
|
3/29/22
|
3/31/23
|
3/19/24
|
|
1st Jan change
|
Capi.
|
---|
| -71.58% | 2.79M | | +8.20% | 7.78B | | +10.20% | 6.52B | | -8.10% | 3.67B | | -13.13% | 3.44B | | -14.57% | 1.17B | | +8.34% | 934M | | -42.27% | 879M | | -18.90% | 836M | | -16.45% | 802M |
Special Foods & Wellbeing Products
|